Aspirin sensitivity
MacLaren, W.R.
Northwest Medicine 69(6): 44-45
1970
ISSN/ISBN: 0029-3385 PMID: 5430518 Document Number: 29746
Document emailed within 1 workday
Related Documents
Michel, O.; Naeije, N.; Bracamonte, M.; Duchateau, J.; Sergysels, R. 1984: Decreased sensitivity to tartrazine after aspirin desensitization in an asthmatic patient intolerant to both aspirin and tartrazine Annals of Allergy 52(5): 368-370Szmidt, M.; Grzelewska-Rzymowska, I.; Rozniecki, J.; Grzegorczyk, J. 1991: Neutrophil chemotactic activity after administration of aspirin during aspirin tolerance in patients with asthma and aspirin hypersensitivity Pneumonologia i Alergologia Polska 59(1-2): 16-21
Yokoyama, T.; Yamashita, K.; Yamasaki, F.; Ueta, T.; Manabe, M.; Nishiyama, T. 2003: Aspirin reversal--an incremental administration of aspirin shortens the bleeding time prolonged by low-dose aspirin Masui. Japanese Journal of Anesthesiology 52(4): 399-401
Nahar, I.K.; Muqim, A.T.; Al-Qhouti, B.I.; Al-Herz, A.A.; Shehab, D.K.; Uppal, S.S.; Khadadah, M.E. 2006: The use of etoricoxib in patients with bronchial asthma associated with aspirin sensitivity Saudi Medical Journal 27(1): 119-120
Katz, L.B.; Shriver, D.A. 1989: Rioprostil heals pre-existing aspirin-induced gastric lesions in dogs during daily aspirin administration without altering the anti-inflammatory or analgesic efficacy of aspirin Journal of Pharmacology and Experimental Therapeutics 251(2): 774-781
Kirichenko, A.A.; Mantserova, O.A.; Lebedeva, A.I.; D'iachkova, N.V.; Voloshina, N.M.; Mazurov, V.I.; Nifontov, V.M.; Tyrenko, V.V.; Kolina, I.G.; Cherkashina, A.L.; Shkodina, N.V.; Mazalov, K.V.; Spiropulos, N.A.; Eremenko, I.A.; Kuzin, A.I. 2007: Unstable angina: efficacy and tolerability of therapy with aspirin and aspirin combined with ticlopidine Kardiologiia 47(5): 24-27
Szmidt, M.; Wasiak, W. 1995: The influence of misoprostol on post-aspirin bronchoconstriction in patients with aspirin sensitive asthma Pneumonologia i Alergologia Polska 63(9-10): 544-552
Chiu, J.T. 1985: Effects of chronic aspirin ingestion in aspirin-intolerant asthmatic patients Annals of Allergy 54(3): 259
Cohen, H. 1996: Randomized trial of aspirin versus aspirin and heparin in pregnant women with the antiphospholipid syndrome Annales de Medecine Interne 147(Suppl): 44
Gaciong, Z. 2006: Clopidogrel and aspirin versus aspirin alone in prevention of atherothrombotic events. The results of CHARISMA study Kardiologia Polska 64(5): 548
Cerletti, C.; Latini, R.; Del Maschio, A.; Galletti, F.; Dejana, E.; de Gaetano, G. 1985: Aspirin kinetics and inhibition of platelet thromboxane generation-relevance for a solution of the "aspirin dilemma" Thrombosis and Haemostasis 53(3): 415-418
Petroski, D. 1986: A comparison of enteric-coated aspirin granules with plain and buffered aspirin: a report of two studies American Journal of Gastroenterology 81(1): 26-28
Kowalski, M.L.; Grzelewska-Rzymowska, I.; Szmidt, M.; Rozniecki, J.; Bednarowicz, A. 1987: Fibrinolysis, blood coagulation, and platelet function during aspirin-induced bronchoconstriction in aspirin-intolerant asthmatics Annals of Allergy 58(5): 367-371
Piamsomboon, C.; Laothavorn, P.; Chatlaong, B.; Saguanwong, S.; Nasawadi, C.; Tanprasert, P.; Leelaprute, M.; Intayakorn, U.; Amornsak, N. 2001: Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin after coronary stent implantation: 1 and 6-month follow-up Journal of the Medical Association of Thailand 84(12): 1701-1707
Platelet Receptor Inhibition, I.Ischemic Syndrome Management Study Investigators 1998: A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina New England Journal of Medicine 338(21): 1498-1505
Fishman, P.; Falach-Vaknin, E.; Sredni, B.; Meroni, P.L.; Rudniki, C.; Shoenfeld, Y. 1995: Aspirin modulates interleukin-3 production: additional explanation for the preventive effects of aspirin in antiphospholipid antibody syndrome Journal of Rheumatology 22(6): 1086-1090
Selak, V.; Jackson, R.; Poppe, K.; Kerr, A.; Wells, S. 2018: Are the benefits of aspirin likely to exceed the risk of major bleeds among people in whom aspirin is recommended for the primary prevention of cardiovascular disease? New Zealand Medical Journal 131(1484): 19-25
Saito, E.; Ogata, H.; Shibazaki, T.; Ejima, A.; Inoue, T. 1977: Determination of aspirin--anhydride in commercial aspirin and its preparations Eisei Shikenjo Hokoku. Bulletin of National Institute of Hygienic Sciences 95: 35-38
Bretagne, J.F.; Feuillu, A.; Gosselin, M.; Gastard, J. 1984: Aspirin and gastroduodenal toxicity. a double-blind endoscopic study of the effects of placebo, aspirin and lysine acetylsalicylate in healthy subjects Gastroenterologie Clinique et Biologique 8(1): 28-32
Young, F.E.; Nightingale, S.L.; Temple, R.A. 1988: The preliminary report of the findings of the aspirin component of the ongoing Physicians' Health Study. The FDA perspective on aspirin for the primary prevention of myocardial infarction JAMA 259(21): 3158-3160